Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

FDA Approval Summary: Revised Indication and Dosing Regimen for Ponatinib Based on the Results of the OPTIC Trial

E. Dianne Pulte,Haiyan Chen,Lauren S. L. Price,Ramadevi Gudi,Hongshan Li,Olanrewaju O. Okusanya,Lian Ma,Lisa Rodriguez,Jonathon Vallejo,Kelly J. Norsworthy,R. Angelo de Claro,Marc R. Theoret,Richard Pazdur

ONCOLOGIST（2022）

Cited 16|Views21
No score
Key words
ponatinib, chronic-phase chronic myeloid leukemia, FDA approval
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined